Ethicon Logo

"Always
Prepared"

Trust the SURGICEL® Family of Absorbable Hemostats for every continuous oozing bleeding situation.

Card-Row-1--Surgicel-Powder_RGB_shadow-copy_REV

SURGICEL® Powder

Card-Row-2---SURGICEL_SNoW_box_shadow-copy_REV

SURGICEL SNoW™

Card-Row-3---SURGICEL_Fibrillar_box_shadow-copy_REV

SURGICEL® FIBRILLAR™

One family. 5 products. Trusted for 50+ years.1-4

SURGICEL® is the world's #1 trusted brand of adjunctive hemostats with over 50 years of proven safety and efficacy.1-4 SURGICEL® has the most extensive clinical data of any topical adjunctive hemostat and has been studied across a variety of procedures and surgical specialties including Cardiovascular, Neurological, General, Obstetric, Gynecologic, Urologic, Orthopedic, Plastic, and ENT.3,5,6 

Topic Card 1 - Surgicel family products_shadow copy_REV

Fast, effective, bactericidal2,4,7
 

SURGICEL® offers surgeons documented fast hemostasis and a proven record of efficacy for a broad range of bleeding situations.4,7 Furthermore, SURGICEL® Original Absorbable Hemostat has consistently shown bactericidal properties in vitro against the 5 main pathogens associated with surgical site infections.2

Topic Card 2 - Bacteria infographic image_REV

Lower resource use and hospital costs8† 

Better patient and economic outcomes were associated with SURGICEL SNoW™ Absorbable Hemostat and SURGICEL® FIBRILLAR™ Absorbable Hemostat compared with SURGICEL® Original Absorbable Hemostat.8† Furthermore, 1 layer of these advanced brands is more effective than 4 layers of SURGICEL Original Hemostat.7,9

Card 3 Surgicel

The next generation: SURGICEL® Powder 

The newest member of the #1 trusted brand of adjunctive hemostats, SURGICEL® Powder Absorbable Hemostat is built to provide efficient control of continuous oozing bleeding on broad surfaces.10 Its unique structure penetrates the surface of the blood to get to the source of bleeding, forming a clot that has been demonstrated to sustain hemostasis even when it is irrigated.11,12‡
 

Topic Card 4 - 074143-170606_Surgicel Powder Product Overview_Open_Screen grab copy_REV

Increased hemostatic capacity7,9

One layer of SURGICEL SNoW™ Absorbable Hemostat or SURGICEL® FIBRILLAR™ Absorbable Hemostat is more effective than four layers of SURGICEL® Original Absorbable Hemostat.7,9

References

* MRSA, MRSE, VRE, E. coli, and P. aeruginosa 

† Analysis involved adults who underwent brain/cerebral, cardiovascular (valve surgery and coronary artery bypass graft), and carotid endarterectomy (CEA) procedures between January 2011 and December 2012. However, for CEA procedures, there was no statistically significant difference in ICU costs for patients using Advanced ORCs compared to SURGICEL Original. 

‡ Based on preclinical testing in a swine acute liver biopsy model 



1. US Market Share Report, October 2016. Ethicon, Inc.


2. SURGICEL® Technical Report, 2018. Ethicon, Inc.  


3. Hong YM, Loughlin KR. The use of hemostatic agents and sealants in urology. J Urol. 2006;176(6 Pt 1):2367-2374.


4. SURGICEL® Absorbable Hemostat. Full Prescribing Information. Ethicon, Inc. 


5. STRIVE Data. January 2011. Ethicon, Inc.


6. A Compendium of Scientific Literature. 2016. Ethicon, Inc.


7. Harrington C. Hemostatic effectiveness of SURGICEL, SURGICEL Nu-Knit, and SURGICEL Fibrillar in a swine spleen model. August 1, 2005. Ethicon, Inc. 


8. Martyn D, Kocharian R, Lim S, et al. Reduction in hospital costs and resource consumption associated with the use of advanced topical hemostats during inpatient procedures. J Med Econ. 2015;18(6):474-481.


9. Shnoda P. Project Snow: Comparison of SURGICEL non-woven and SURGICEL Original in the acute swine splenic incision hemostasis model. Report 08-0252. January 29, 2009.

10. MacDonald M. SURGICEL® Powder versus competitive powdered hemostats. Final Report, PSE Accession No. 16-0006, Project No. 16438. March 8, 2016. Ethicon, Inc. 


11. Surface energy/tension analysis among ORC Aggregate, ORC Fine Fiber, and Arista – Project PIXIE. Ethicon, Inc.


12. MacDonald M. SURGICEL® Powder versus ARISTA™ AH. Final Report, PSE Accession No. 15-0120, Project No. 16438. September 2, 2015. Ethicon, Inc. 

 

SURGICEL Essential Product Information

  • INDICATIONS

SURGICEL® Absorbable Hemostat (oxidized regenerated cellulose) is used adjunctively in surgical procedures to assist in the control of capillary, venous, and small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective. SURGICEL® ORIGINAL, SURGICEL®FIBRILLAR™, SURGICEL® NU-KNIT®, and SURGICEL®SNoW™ Absorbable Hemostats can be cut to size for use in endoscopic procedures.

  • PRECAUTIONS

Use only as much SURGICEL® Absorbable Hemostat as is necessary for hemostasis, holding it firmly in place until bleeding stops. Remove any excess before surgical closure in order to facilitate absorption and minimize the possibility of foreign body reaction.

In urological procedures, minimal amounts of SURGICEL® Absorbable Hemostat should be used and care must be exercised to prevent plugging of the urethra, ureter, or a catheter by dislodged portions of the product.

Since absorption of SURGICEL® Absorbable Hemostat could be prevented in chemically cauterized areas, its use should not be preceded by application of silver nitrate or any other escharotic chemicals.

If SURGICEL® Absorbable Hemostat is used temporarily to line the cavity of large open wounds, it should be placed so as not to overlap the skin edges. It should also be removed from open wounds by forceps or by irrigation with sterile water or saline solution after bleeding has stopped.

Precautions should be taken in otorhinolaryngologic surgery to assure that none of the material is aspirated by the patient. (Examples: controlling hemorrhage after tonsillectomy and controlling epistaxis.)

Care should be taken not to apply SURGICEL® Absorbable Hemostat too tightly when it is used as a wrap during vascular surgery (see Adverse Reactions section of the complete product package insert).

  • ADVERSE EVENTS

“Encapsulation” of fluid and foreign body reactions have been reported.

There have been reports of stenotic effect when SURGICEL® Absorbable Hemostat has been applied as a wrap during vascular surgery.

Paralysis and nerve damage have been reported when SURGICEL® Absorbable Hemostat was used around, in, or in proximity to foramina in bone, areas of bony confine, the spinal cord, and/or the optic nerve and chiasm.

Blindness has been reported in connection with surgical repair of a lacerated left frontal lobe when SURGICEL® Absorbable Hemostat was placed in the anterior cranial fossa.

Possible prolongation of drainage in cholecystectomies and difficulty passing urine per urethra after prostatectomy have been reported.

For more information, please consult your doctor or for product quality and technical questions, call 1-800-795-0012. For complete product information including indications, contraindications, warnings, precautions, and adverse reactions, please reference the individual product package inserts.

 

SURGICEL® Powder Absorbable Hemostat Essential Product Information

  • INDICATIONS

SURGICEL® Powder (oxidized regenerated cellulose) is used adjunctively in surgical procedures to assist in the control of capillary, venous, and small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective.

  • CONTRAINDICATIONS

Do not inject or place SURGICEL® Powder into an open blood vessel. Do not use to treat bleeding from large defects in arteries or veins.

SURGICEL® Powder should not be used to control hemorrhage from large arteries or veins.

When SURGICEL® Powder is used to help achieve hemostasis in, around, or in proximity to foramina in bone, areas of bony confine, the spinal cord, or the optic nerve and chiasm, it must always be removed after hemostasis is achieved since it will swell and could exert unwanted pressure.

SURGICEL® Powder should not be used for implantation in bone defects, such as fractures, since there is a possibility of interference with callus formation and a theoretical chance of cyst formation.

  • WARNINGS

Closing with SURGICEL® Powder in a contaminated wound without drainage may lead to complications and should be avoided.

SURGICEL® Powder should not be impregnated with anti-infective agents or with other materials such as buffering or hemostatic substances. 

SURGICEL® Powder is dry and there may be difficulties in precise delivery under certain circumstances. Unintentional device placement may result in powder scattering and device migration that may increase the risk of adhesion formation. 

Although SURGICEL® Powder is bactericidal against a wide range of pathogenic microorganisms, it is not intended as a substitute for systemically administered therapeutic or prophylactic antimicrobial agents to control or to prevent postoperative infections.

Do not attempt to trim the applicator tip.

  • PRECAUTIONS

SURGICEL® Powder should not be used in conjunction with autologous blood salvage circuits, because its fragments may pass through the transfusion filters of blood-scavenging systems.

Use only as much SURGICEL® Powder (oxidized regenerated cellulose) as is necessary and apply only where needed for hemostasis. Remove any excess before surgical closure in order to facilitate absorption and to minimize the possibility of foreign body reaction.

In urological procedures, minimal amounts of SURGICEL® Powder should be used and care must be exercised to prevent plugging of the urethra, ureter, or a catheter by dislodged portions of the product.

Since absorption of SURGICEL® Powder could be prevented in chemically cauterized areas, its use should not be preceded by application of silver nitrate or any other escharotic chemicals.

If SURGICEL® Powder is used temporarily to line the cavity of open wounds, it should be removed by irrigation with sterile water or saline solution after bleeding has stopped.

Precautions should be taken in otorhinolaryngologic surgery to ensure that none of the material is aspirated by the patient (e.g., controlling hemorrhage after tonsillectomy and controlling epistaxis).

This applicator tip is not intended for laparoscopic or other endoscopic use.

  • ADVERSE EVENTS 

Paralysis and nerve damage have been reported when other SURGICEL® products were used around, in, or in proximity to foramina in bone, areas of bony confine, the spinal cord, and/or the optic nerve and chiasm. 

Blindness has been reported in connection with surgical repair of a lacerated left frontal lobe when other SURGICEL® products were placed in the anterior cranial fossa (see WARNINGS and PRECAUTIONS).

Foreign body reactions have been reported with other products from the SURGICEL® Family of Absorbable Hemostats.

Burning has been reported when other SURGICEL® products were applied after nasal polyp removal. Headache, burning, stinging, and sneezing in epistaxis and other rhinological procedures, and stinging when SURGICEL® product was applied on surface wounds (varicose ulcerations, dermabrasions, and donor sites) have also been reported.

For more information and technical questions, call 1-800-795-0012.  For complete information including indications, contraindications, warnings, precautions, adverse reactions, and directions for use, consult the product package insert.